Relationship between serum adipocytokine levels and metabolic syndrome in menopausal women

References

• Executive summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497
   PubMed Web of Science ®Google Scholar
• Carr M C. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003; 88: 2404–2411
   PubMed Web of Science ®Google Scholar
• Poehlman E T, Toth M J, Gardner A W. Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med 1995; 123: 673–675
   PubMed Web of Science ®Google Scholar
• Park Y W, Zhu S, Palaniappan L, Heshka S, Carnethon M R, Heymsfield S B. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 2003; 163: 427–436
   PubMed Web of Science ®Google Scholar
• Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497
   PubMed Web of Science ®Google Scholar
• World Health Organization Western Pacific Region, International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. Health Communications Australia Pty Limited, Sydney 2000; 56
   Google Scholar
• Haffner S M, Miettinen H, Stern M P. The homeostasis model in the San Antonio Heart Study. Diabetes Care 1997; 20: 1087–1092
   PubMed Web of Science ®Google Scholar
• Hotamisligil G S, Shargill N S, Spiegelman B M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87–91
   PubMed Web of Science ®Google Scholar
• Rush E C, Plank L D, Yajnik C S. Interleukin-6, tumour necrosis factor-alpha and insulin relationships to body composition, metabolism and resting energy expenditure in a migrant Asian Indian population. Clin Endocrinol 2007; 66: 684–690
   PubMed Web of Science ®Google Scholar
• Zavaroni I, Numeroso F, Dongiovanni P, Ardigo D, Valenti L, Fracanzani A, Valtuena S, Delsignore R, Fargion S, Reaven G M. What is the contribution of differences in three measures of tumor necrosis factor-alpha activity to insulin resistance in healthy volunteers. Metabolism 2003; 52: 1593–1596
   PubMed Web of Science ®Google Scholar
• Gwozdziewiczova S, Lichnovska R, Ben Yahia R, Chlup R, Hrebicek J. TNF-alpha in the development of insulin resistance and other disorders in metabolic syndrome. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005; 149: 109–117
   PubMedGoogle Scholar
• Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79–83
   PubMed Web of Science ®Google Scholar
• Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595–1599
   PubMed Web of Science ®Google Scholar
• Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 2473–2476
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman M L, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7: 941–946
   PubMed Web of Science ®Google Scholar
• Yang W S, Lee W J, Funahashi T, Tanaka S, Matsuzawa Y, Chao C L, Chen C L, Tai T Y, Chuang L M. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001; 86: 3815–3819
   PubMed Web of Science ®Google Scholar
• Kim S M, Cho K H, Park H S. Relationship between plasma adiponectin levels and the metabolic syndrome among Korean people. Endocr J 2006; 53: 247–254
   PubMed Web of Science ®Google Scholar
• Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, Nagai M, Matsuzawa Y, Funahashi T. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004; 68: 975–981
   PubMed Web of Science ®Google Scholar
• Steppan C M, Bailey S T, Bhat S, Brown E J, Banerjee R R, Wright C M, Patel H R, Ahima R S, Lazar M A. The hormone resistin links obesity to diabetes. Nature 2001; 409: 307–312
   PubMed Web of Science ®Google Scholar
• Heilbronn L K, Rood J, Janderova L, Albu J B, Kelley D E, Ravussin E, Smith S R. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J Clin Endocrinol Metab 2004; 89: 1844–1848
   PubMed Web of Science ®Google Scholar
• Osawa H, Tabara Y, Kawamoto R, Ohashi J, Ochi M, Onuma H, Nishida W, Yamada K, Nakura J, Kohara K, Miki T, Makino H. Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and highsensitivity C-reactive protein in the Japanese general population. Diabetes Care 2007; 30: 1501–1506
   PubMed Web of Science ®Google Scholar
• Lee J H, Chan J L, Yiannakouris N, Kontogianni M, Estrada E, Seip R, Orlova C, Mantzoros C S. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab 2003; 88: 4848–4856
   PubMed Web of Science ®Google Scholar
• Vozarova de Court, Degawa-Yamauchi M, Considine R V, Tataranni P A. High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians. Diabetes 2004; 53: 1279–1284
   PubMedGoogle Scholar
• Weisberg S P, McCann D, Desai M, Rosenbaum M, Leibel R L, Ferrante A W, Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796–1808
   PubMed Web of Science ®Google Scholar
• Borst S E, Conover C F, Bagby G J. Association of resistin with visceral fat and muscle insulin resistance. Cytokine 2005; 32: 39–44
   PubMed Web of Science ®Google Scholar
• Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2005; 48: 1684–1699
   Google Scholar